Authored By: Sarah
18 Oct 2024

increase in prevalence of infertility is driving the Human Chorionic Gonadotropin (Hcg) Market

Latest News:- Human Chorionic Gonadotropin (Hcg) Market: Natural source extraction is expected to lead the Technology segment during 2024-2028

Technavio analyzes that the Human Chorionic Gonadotropin (Hcg) Market is expected to grow at a CAGR of 4.5% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 193.8 million.There are various factors that contribute to the growth of the market. The Human Chorionic Gonadotropin (hCG) market is experiencing significant growth due to the rising prevalence of infertility issues worldwide. Infertility affects millions of individuals and couples, leading to an increased demand for hCG treatments. hCG is a hormone produced during pregnancy that helps maintain the corpus luteum, which in turn supports the production of progesterone. Infertility treatments, such as in vitro fertilization (IVF) and intrauterine insemination (IUI), often involve the use of hCG injections to stimulate ovulation and support early pregnancy. The global infertility market is projected to reach USD23.5 billion by 2025, and the hCG market is expected to grow in tandem due to its essential role in infertility treatments.

In the healthcare industry, Human Chorionic Gonadotropin (HCG) holds significant value due to its essential role in pregnancy and various infertility treatments. Exclusively produced by the syncytiotrophin in the human placenta, HCG can also be derived from the urine of pregnant women. While purified human menopausal gonadotropin (HMG) is a natural alternative extracted from postmenopausal women's urine, containing FSH, LH, and a minimal amount of HCG. The escalating demand for HCG is driven by the growing accessibility of infertility treatments and services, as well as the increasing prevalence of infertility issues. Furthermore, the rising incidence of hypogonadism-related illnesses in men, predominantly in older adults, significantly contributes to the expansion of the global HCG market. Infertility issues, such as sperm disorders, undescended testicles, blighted ovum, miscarriage, ectopic pregnancy, and congenital disorders, are increasingly being addressed through advanced treatments like in-vitro fertilization (IVF) and intrauterine insemination (IUI), which rely on HCG for successful outcomes. 

Know which region is leading the market growth by requesting a sample report

Human Chorionic Gonadotropin (Hcg) Market Segmentation

  • Technology
    • Natural source extraction
    • Recombinant technology
  • Geography
    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

Top Performing Companies

As per our research findings, here are some of the key competitors that are leading the industry

  • Ferring BV
  • Fresenius Kabi AG
  • Intas Pharmaceuticals Ltd.
  • Lee BioSolutions Inc
  • Lupin Ltd.
  • Merck and Co. Inc.
  • Sanzyme Pvt. Ltd.
  • Serum Institute of India Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • The Cigna Group

Find out what is trending in the market by accessing the free PDF report

Research Analysis Overview

The HCG market revolves around the hormone produced by the placenta during pregnancy, which plays a crucial role in maintaining the pregnancy by stimulating the production of progesterone and estrogen. HCG levels rise after conception and can be detected through blood tests, urine tests, or at-home pregnancy tests during the first trimester. HCG is essential for the development of the uterine lining and the growth of the embryo. Healthcare providers use HCG to monitor pregnancy progress, diagnose infertility, and manage conditions like blighted ovum, miscarriage, ectopic pregnancy, and congenital disorders. HCG is also used in assisted reproductive technologies like IVF and IUI, and can indicate ovulation, high testosterone levels, undescended testicles, and low sperm count. HCG is a pregnancy hormone that signals the fertilized egg's implantation and the beginning of the pregnancy journey.

Market Research Overview

The global HCG market, a segment of the larger pharmaceuticals industry, encompasses entities involved in the research and development (R&D) or production of various HCG-related offerings, including generic and non-generic drugs, and veterinary medications. According to Technavio, the healthcare market size is determined by the consolidated revenue generated by providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Factors fueling the expansion of the pharmaceuticals market include demographic shifts, such as the aging population. By 2050, approximately one-quarter of the US population and Europe's population ratio is projected to surpass 60 years old. This demographic trend is anticipated to create substantial demand for HCG treatments, as HCG plays a crucial role in pregnancy maintenance by stimulating the production of the uterine lining and supporting the embryo's development. Consequently, increasing life expectancy is a significant growth driver for the HCG market.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Reasons to Consider Purchasing Technavio Market Research Report

  • Current Market Insights: Our reports offer valuable information on the latest market intelligence, competitor strategies, trends, industry changes, customer preferences, and forecasted market opportunities to aid in informed business decisions.

  • Extensive Experience: With over 20 years in market research, Technavio is a trusted name, having published more than 21,000 reports across various industries and regions.

  • High ROI Through In-Depth Research: Technavio specializes in tailored market research reports to meet specific business needs, exploring particular markets, product segments, and demographics. We are also recognized for delivering significant returns on investment through our comprehensive data collection at affordable prices.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.

Document